Jos Rijntjes

1.2k citations

24 papers · 777 indexed · h-index 14

Co-authors: Patricia J.T.A. Groenen Pieter Wesseling Eddy van der Maarel D. van Dorp Goos N.P. van Muijen Sandra Boots‐Sprenger Angelique Sijben Judith W. M. Jeuken
Topics: Lymphoma Diagnosis and Treatment (9 papers)Chronic Lymphocytic Leukemia Research (7 papers)Glioma Diagnosis and Treatment (4 papers)
Cited by: Genetics Pathology and Forensic Medicine Cancer Research
Journals: Bioinformatics British Journal of Cancer International Journal of Cancer
Partner nations: Netherlands Germany United States

In The Last Decade

Jos Rijntjes

24 papers receiving 749 citations

Peers

Countries citing papers authored by Jos Rijntjes

Since Specialization

Citations

This map shows the geographic impact of Jos Rijntjes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jos Rijntjes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jos Rijntjes more than expected).

Fields of papers citing papers by Jos Rijntjes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jos Rijntjes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jos Rijntjes. The network helps show where Jos Rijntjes may publish in the future.

Co-authorship network of co-authors of Jos Rijntjes

This figure shows the co-authorship network connecting the top 25 collaborators of Jos Rijntjes. A scholar is included among the top collaborators of Jos Rijntjes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jos Rijntjes. Jos Rijntjes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Extranodal marginal zone lymphoma clonotypes are detectable prior to eMZL diagnosis in tissue biopsies and peripheral blood of Sjögren’s syndrome patients through immunogenetics 2023 ·Frontiers in Oncology ·(unknown),(unknown),(unknown),Cornelia G van Helden-Meeuwsen,Paul Van Daele,Zana Brkić,Jos Rijntjes,Konnie M. Hebeda,Patricia J.T.A. Groenen,Marjan A. Versnel,Rogier M. Thurlings,Anton W. Langerak	4
2	Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma 2023 ·HemaSphere ·(unknown),(unknown),(unknown),(unknown),Jos Rijntjes,Annemiek B. van Spriel,Ellen van der Spek,Hans Pruijt,Leonie I. Kroeze,Konnie M. Hebeda,Sandra Croockewit,Wendy B.C. Stevens,J. Han van Krieken,Patricia J.T.A. Groenen,Michiel van den Brand,Blanca Scheijen	4
3	PAX5 P80R-mutated B-cell acute lymphoblastic leukemia with transformation to histiocytic sarcoma: clonal evolution assessment using NGS-based immunoglobulin clonality and mutation analysis 2022 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Leonie I. Kroeze,Blanca Scheijen,Konnie M. Hebeda,Jos Rijntjes,(unknown),Dorothea Evers,Willemijn Hobo,Patricia J.T.A. Groenen,Michiel van den Brand	4
4	Next-Generation Sequencing–Based Clonality Assessment of Ig Gene Rearrangements 2021 ·Journal of Molecular Diagnostics ·Michiel van den Brand,Jos Rijntjes,Markus Möbs,Julia Steinhilber,(unknown),(unknown),Leonie I. Kroeze,Tomáš Reigl,(unknown),Nikos Darzentas,(unknown),Blanca Scheijen,Frédéric Davi,Hesham Eldaly,Hongxiang Liu,Ioannis Anagnostopoulos,Michael Hummel,Falko Fend,Anton W. Langerak,Patricia J.T.A. Groenen	23
5	Multiple Immunoglobulin κ Gene Rearrangements within a Single Clone Unraveled by Next-Generation Sequencing–Based Clonality Assessment 2021 ·Journal of Molecular Diagnostics ·(unknown),Leonie I. Kroeze,Jos Rijntjes,(unknown),Konnie M. Hebeda,Nikos Darzentas,Anton W. Langerak,Michiel van den Brand,Patricia J.T.A. Groenen	4
6	Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements 2021 ·Modern Pathology ·(unknown),Michiel van den Brand,Jos Rijntjes,(unknown),(unknown),(unknown),Konnie M. Hebeda,J. Han van Krieken,Patricia J.T.A. Groenen,Blanca Scheijen	12
7	Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS 2019 ·Leukemia ·(unknown),Blanca Scheijen,Ruud W. J. Meijers,Jos Rijntjes,(unknown),Markus Möbs,Julia Steinhilber,Tomáš Reigl,Michiel van den Brand,Michaela Kotrová,(unknown),Mark Catherwood,Κώστας Σταματόπουλος,Monika Brüggemann,F Davi,Nikos Darzentas,Christiane Pott,Falko Fend,Michael Hummel,A. W. Langerak,Patricia J.T.A. Groenen	79
8	Immunoglobulin rearrangement analysis from multiple lesions in the same patient using next‐generation sequencing 2015 ·Histopathology ·Silke Appenzeller,Christian Gilissen,Jos Rijntjes,Bastiaan B.J. Tops,(unknown),Konnie M. Hebeda,Loes H.C. Nissen,Bas E. Dutilh,J. Han van Krieken,Patricia J.T.A. Groenen	4
9	Whole-genome copy-number analysis identifies new leads for chromosomal aberrations involved in the oncogenesis and metastastic behavior of uveal melanomas 2015 ·Melanoma Research ·Adriana C. H. van Engen–van Grunsven,Marjolein P. Baar,Rolph Pfundt,Jos Rijntjes,Heidi V.N. Küsters‐Vandevelde,(unknown),J. E. E. Keunen,(unknown),Pieter Wesseling,Willeke A.M. Blokx,Patricia J.T.A. Groenen	13
10	NRAS mutations are more prevalent than KIT mutations in melanoma of the female urogenital tract—A study of 24 cases from the Netherlands 2014 ·Gynecologic Oncology ·Adriana C. H. van Engen–van Grunsven,Heidi V.N. Küsters‐Vandevelde,Joanne A. de Hullu,(unknown),Jos Rijntjes,Judith V.M.G. Bovée,Patricia J.T.A. Groenen,Willeke A.M. Blokx	29
11	Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor 2014 ·Acta Neuropathologica Communications ·Heidi V.N. Küsters‐Vandevelde,Annelieke E.C.A.B. Willemsen,Patricia J.T.A. Groenen,Benno Küsters,Martin Lammens,Pieter Wesseling,(unknown),Jos Rijntjes,Hans Delye,Michèl A.A.P. Willemsen,Carla M. van Herpen,Willeke A.M. Blokx	45
12	Mutations in G Protein Encoding Genes and Chromosomal Alterations in Primary Leptomeningeal Melanocytic Neoplasms 2014 ·Pathology & Oncology Research ·Heidi V.N. Küsters‐Vandevelde,(unknown),Sarah E. Coupland,Sarah L. Lake,Jos Rijntjes,Rolph Pfundt,Benno Küsters,Pieter Wesseling,Willeke A.M. Blokx,Patricia J.T.A. Groenen	31
13	Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution 2013 ·Modern Pathology ·Sandra Boots‐Sprenger,Angelique Sijben,Jos Rijntjes,Bastiaan B.J. Tops,Albert J. S. Idema,Andreana L. Rivera,Fonnet E. Bleeker,Anja Gijtenbeek,Kristin Diefes,Lindsey Heathcock,Kenneth Aldape,Judith W. M. Jeuken,Pieter Wesseling	83
14	Protein profiling in pathology: Analysis and evaluation of 239 frozen tissue biopsies for diagnosis of B‐cell lymphomas 2010 ·PROTEOMICS - CLINICAL APPLICATIONS ·(unknown),Ton Feuth,John Raemaekers,Jos Rijntjes,Jos W. R. Meijer,Pieter J. Westenend,Joop van Baarlen,J. Han van Krieken,Konnie M. Hebeda,Patricia J.T.A. Groenen	7
15	The Nature and Timing of Specific Copy Number Changes in the Course of Molecular Progression in Diffuse Gliomas: Further Elucidation of Their Genetic “Life Story” 2010 ·Brain Pathology ·Judith W. M. Jeuken,Angelique Sijben,Fonnet E. Bleeker,Sandra Boots‐Sprenger,Jos Rijntjes,Johanna M. M. Gijtenbeek,Wolf Mueller,Pieter Wesseling	17
16	Robust Detection of EGFR Copy Number Changes and EGFR Variant III: Technical Aspects and Relevance for Glioma Diagnostics 2009 ·Brain Pathology ·Judith W. M. Jeuken,Angelique Sijben,Cristina Alenda,Jos Rijntjes,(unknown),Sandra Boots‐Sprenger,Roger E. McLendon,Pieter Wesseling	65
17	Type I collagen expression contributes to angiogenesis and the development of deeply invasive cutaneous melanoma 2007 ·International Journal of Cancer ·Léon C.L.T. van Kempen,Jos Rijntjes,(unknown),Silvia Vincent‐Naulleau,Marie‐Jeanne P. Gerritsen,Dirk J. Ruiter,Marcory C. R. F. van Dijk,Claudine Geffrotin,Goos N.P. van Muijen	61
18	Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays 2005 ·British Journal of Cancer ·Nicole de Wit,Jos Rijntjes,J H S Diepstra,Toin H. Van Kuppevelt,Ulrich H. Weidle,D. J. Ruiter,Goos N.P. van Muijen	85
19	Type I collagen synthesis parallels the conversion of keratinocytic intraepidermal neoplasia to cutaneous squamous cell carcinoma 2004 ·The Journal of Pathology ·Léon C.L.T. van Kempen,Jos Rijntjes,An Claes,Willeke A.M. Blokx,(unknown),Dirk J. Ruiter,(unknown)	18
20	Fucosyl Glycopeptide Profiles of Keratinocytes from Various Epithelial Tissues of the Rabbit in Relation to Differentiation In Vivo and In Vitro 1984 ·Journal of Investigative Dermatology ·P.E.J. van Erp,Mieke Bergers,(unknown),Jan Koedam,Jos Rijntjes	2

About Jos Rijntjes

Jos Rijntjes is a scholar working on Genetics, Pathology and Forensic Medicine and Cancer Research, having authored 24 papers that have together received 777 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Glioma Diagnosis and Treatment (4 papers). The work is most often cited by research in Genetics (258 citations), Pathology and Forensic Medicine (174 citations) and Cancer Research (140 citations). Jos Rijntjes has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Patricia J.T.A. Groenen, Pieter Wesseling, Eddy van der Maarel, D. van Dorp, Goos N.P. van Muijen, Sandra Boots‐Sprenger, Angelique Sijben, Judith W. M. Jeuken, Willeke A.M. Blokx and Ulrich H. Weidle. Their work appears in journals such as Bioinformatics, British Journal of Cancer and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact